Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last 166,000 KRW
Change Today -2,000.00 / -1.19%
Volume 33.5K
000640 On Other Exchanges
Symbol
Exchange
Korea SE
As of 2:23 AM 04/1/15 All times are local (Market data is delayed by at least 15 minutes).

dong-a socio holdings co ltd (000640) Snapshot

Open
169,000
Previous Close
168,000
Day High
173,000
Day Low
164,000
52 Week High
03/20/15 - 182,500
52 Week Low
01/26/15 - 105,500
Market Cap
743.9B
Average Volume 10 Days
112.5K
EPS TTM
397.00
Shares Outstanding
4.5M
EX-Date
12/29/14
P/E TM
418.1x
Dividend
1,000
Dividend Yield
0.60%
Current Stock Chart for DONG-A SOCIO HOLDINGS CO LTD (000640)

Related News

No related news articles were found.

dong-a socio holdings co ltd (000640) Related Businessweek News

No Related Businessweek News Found

dong-a socio holdings co ltd (000640) Details

Dong-A Socio Holdings Co., Ltd., a pharmaceutical company, is engaged in the research and development, manufacture, and sale of over-the-counter drugs, health functional foods, and quasi-drugs worldwide. It offers Stillen for the treatment of gastritis; Zydena for erectile dysfunction treatment; Motilitone used in functional dyspepsia treatment; Orodipine and Orosartan for hypertension treatment; Growtropin II, a human growth hormone; and Leucostim, a biosimilar for use in Neutropenia treatment. The company also provides Opalmon to treat lumbar spinal stenosis; Talion for allergic rhinitis, urticaria, and pruritus treatment; Gaster and Pantoline for peptic ulcer treatment; Nicetile for dementia treatment; Flivas for benign prostatic hyperplasia treatment; Epocelin, an antibiotic; Onon used in bronchial asthma and allergic rhinitis treatment; Valtrex, an antiviral agent; Butyris, a petit plastic surgery filler; and Nenoma for premature ejaculation treatment. In addition, it offers Lipinon for hyperlipidemia treatment; Plavitor, a platelet aggregation inhibitor; Glimel for diabetes treatment; Cozartan for hypertension treatment; Gabapentin for neuropathic pain treatment; Aclofen for anti-inflammatory analgesic treatment; and Glinib used in chronic myeloid leukemia treatment. The company offers its products in the form of tablets, capsules, tonic, and injections. Dong-A Socio Holdings Co., Ltd. was founded in 1932 and is headquartered in Seoul, South Korea.

Founded in 1932

dong-a socio holdings co ltd (000640) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

dong-a socio holdings co ltd (000640) Key Developments

Dong-A Socio Holdings Co. Ltd., Annual General Meeting, Mar 20, 2015

Dong-A Socio Holdings Co. Ltd., Annual General Meeting, Mar 20, 2015., at 10:00 Korea Standard Time. Location: Dongdaemun-gu,Cheonho as 14 road 18. Agenda: To consider the financial statements (appropriation of retained earnings (not) included) and the consolidated financial statements; to consider appointment of inside director and outside director; to consider director remuneration; and to consider approval of the division plan.

Dong-A Socio Holdings Co. Ltd., Annual General Meeting, Mar 21, 2014

Dong-A Socio Holdings Co. Ltd., Annual General Meeting, Mar 21, 2014., at 10:00 Korea Standard Time. Location: 14 way as Cheonho 18 , Dongdaemun-gu. Agenda: To consider financial statements of retained earnings and approval of the consolidated financial statements; to consider election of Directors; to consider appointment of Audit; to consider approval of director remuneration; to consider attendance of outside Directors; and to consider other references useful for making investment decisions.

Dong-A PHARM.CO.,LTD. Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013

Dong-A PHARM.CO.,LTD. Presents at Fifth Annual ChinaBio(R) Partnering Forum 2013, May-29-2013 . Venue: Shangri-La Hotel, 29 Zizhuyuan Road, Beijing 100089, China.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
000640:KS 166,000.00 KRW -2,000.00

000640 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lotte Chilsung Beverage Co Ltd 1,792,000 KRW +69,000
View Industry Companies
 

Industry Analysis

000640

Industry Average

Valuation 000640 Industry Range
Price/Earnings 100.0x
Price/Sales 1.2x
Price/Book 1.5x
Price/Cash Flow 185.9x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DONG-A SOCIO HOLDINGS CO LTD, please visit www.donga.co.kr. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.